Literature DB >> 29874128

Laminin-dystroglycan signaling regulates retinal arteriogenesis.

Saptarshi Biswas1,2,3, Jared Watters1,2,3, Galina Bachay1,2,3, Shweta Varshney4,5, Dale D Hunter1,2,3, Huaiyu Hu1,2,3, William J Brunken1,2,3.   

Abstract

Proper arteriovenous morphogenesis is crucial for maintaining normal tissue perfusion. However, our understanding of how arterial morphogenesis is regulated in the CNS is incomplete. In this study, we asked whether vascular basement membrane (BM) laminins, specifically the γ3-containing isoforms, regulate retinal arterial morphogenesis. We provide evidence that Laminin-γ3 is deposited at both arterial and venous BMs during arteriogenesis. Vascular BM Laminin-γ3 bound dystroglycan (DG), a laminin receptor preferentially expressed by arterial endothelial cells (ECs) during arteriogenesis. Blockade of laminin-DG binding in vitro led to decreased Delta-like ligand (DLL)-4 expression in ECs. Moreover, genetic deletion of the Laminin-γ3- and EC-specific deletion of DG led to similar defects in retinal arteriogenesis, including reduced Dll4 expression, hyperbranching and reduced smooth muscle coverage. These results implicate a newly identified Laminin-γ3-DG signaling cascade that regulates arterial Dll4/Notch signaling to specify and stabilize retinal arteries.-Biswas, S., Watters, J., Bachay, G., Varshney, S., Hunter, D. D., Hu, H., Brunken, W. J. Laminin-dystroglycan signaling regulates retinal arteriogenesis.

Entities:  

Keywords:  CNS angiogenesis; basement membrane; extracellular matrix; vascular remodeling

Year:  2018        PMID: 29874128      PMCID: PMC6181633          DOI: 10.1096/fj.201800232R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  40 in total

Review 1.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

2.  The Dll4/Notch pathway controls postangiogenic blood vessel remodeling and regression by modulating vasoconstriction and blood flow.

Authors:  Ivan B Lobov; Eunice Cheung; Rajeev Wudali; Jingtai Cao; Gabor Halasz; Yi Wei; Aris Economides; Hsin C Lin; Nicholas Papadopoulos; George D Yancopoulos; Stanley J Wiegand
Journal:  Blood       Date:  2011-04-15       Impact factor: 22.113

3.  Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis.

Authors:  Mats Hellström; Li-Kun Phng; Jennifer J Hofmann; Elisabet Wallgard; Leigh Coultas; Per Lindblom; Jackelyn Alva; Ann-Katrin Nilsson; Linda Karlsson; Nicholas Gaiano; Keejung Yoon; Janet Rossant; M Luisa Iruela-Arispe; Mattias Kalén; Holger Gerhardt; Christer Betsholtz
Journal:  Nature       Date:  2007-01-28       Impact factor: 49.962

4.  Retinal neovascularization, collaterals, and vascular shunts.

Authors:  P Henkind; G N Wise
Journal:  Br J Ophthalmol       Date:  1974-04       Impact factor: 4.638

5.  Laminin-Dependent Interaction between Astrocytes and Microglia: A Role in Retinal Angiogenesis.

Authors:  Saptarshi Biswas; Galina Bachay; Julianne Chu; Dale D Hunter; William J Brunken
Journal:  Am J Pathol       Date:  2017-07-08       Impact factor: 4.307

6.  Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo.

Authors:  Denise Stenzel; Claudio A Franco; Soline Estrach; Amel Mettouchi; Dominique Sauvaget; Ian Rosewell; Andreas Schertel; Hannah Armer; Anna Domogatskaya; Sergey Rodin; Karl Tryggvason; Lucy Collinson; Lydia Sorokin; Holger Gerhardt
Journal:  EMBO Rep       Date:  2011-10-28       Impact factor: 8.807

7.  Dll4-Notch signaling determines the formation of native arterial collateral networks and arterial function in mouse ischemia models.

Authors:  Brunella Cristofaro; Yu Shi; Marcella Faria; Steven Suchting; Aurelie S Leroyer; Alexandre Trindade; Antonio Duarte; Ann C Zovein; M Luisa Iruela-Arispe; Lina R Nih; Nathalie Kubis; Daniel Henrion; Laurent Loufrani; Mihail Todiras; Johanna Schleifenbaum; Maik Gollasch; Zhen W Zhuang; Michael Simons; Anne Eichmann; Ferdinand le Noble
Journal:  Development       Date:  2013-04       Impact factor: 6.868

8.  Nuclear translocation of beta-dystroglycan reveals a distinctive trafficking pattern of autoproteolyzed mucins.

Authors:  Maria Luisa Oppizzi; Armin Akhavan; Manisha Singh; Jimmie E Fata; John L Muschler
Journal:  Traffic       Date:  2008-09-18       Impact factor: 6.215

9.  Hes1 and Hes5 regulate vascular remodeling and arterial specification of endothelial cells in brain vascular development.

Authors:  Masashi Kitagawa; Masato Hojo; Itaru Imayoshi; Masanori Goto; Mitsushige Ando; Toshiyuki Ohtsuka; Ryoichiro Kageyama; Susumu Miyamoto
Journal:  Mech Dev       Date:  2013-07-17       Impact factor: 1.882

10.  Laminins containing the β2 and γ3 chains regulate astrocyte migration and angiogenesis in the retina.

Authors:  Gopalan Gnanaguru; Galina Bachay; Saptarshi Biswas; Germán Pinzón-Duarte; Dale D Hunter; William J Brunken
Journal:  Development       Date:  2013-05       Impact factor: 6.868

View more
  4 in total

Review 1.  Neuronal and glial regulation of CNS angiogenesis and barriergenesis.

Authors:  Saptarshi Biswas; Azzurra Cottarelli; Dritan Agalliu
Journal:  Development       Date:  2020-05-01       Impact factor: 6.868

Review 2.  Basement Membrane Changes in Ischemic Stroke.

Authors:  Minkyung Kang; Yao Yao
Journal:  Stroke       Date:  2020-03-03       Impact factor: 7.914

Review 3.  Designing Cardiovascular Implants Taking in View the Endothelial Basement Membrane.

Authors:  Skadi Lau; Manfred Gossen; Andreas Lendlein
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

4.  Laminin β2 Chain Regulates Cell Cycle Dynamics in the Developing Retina.

Authors:  Dmitri Serjanov; Galina Bachay; Dale D Hunter; William J Brunken
Journal:  Front Cell Dev Biol       Date:  2022-01-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.